These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2867551)

  • 1. A review of some nonopioid actions of dynorphin.
    Walker JM; Moises HC; Friederich MW
    Prog Clin Biol Res; 1985; 192():309-12. PubMed ID: 2867551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl test.
    Tortella FC; Holaday JW
    NIDA Res Monogr; 1986; 75():539-42. PubMed ID: 2893282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor activity in the dentate region of the rat hippocampus.
    Neumaier JF; Chavkin C
    NIDA Res Monogr; 1986; 75():101-4. PubMed ID: 2893261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin content in rabbit reticulocyte and the influence of opioid peptides on calmodulin activity in its membrane.
    Liu JS; Liu Y; Jiao HY; Chin YC
    NIDA Res Monogr; 1986; 75():125-8. PubMed ID: 2893262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
    Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
    Shukla VK; Prasad JA; Lemaire S
    J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some aspects of physiology and pharmacology of endogenous opioid peptides.
    Przewłocki R
    Pol J Pharmacol Pharm; 1984; 36(2-3):137-58. PubMed ID: 6147828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
    Takemori AE; Loh HH; Lee NM
    J Pharmacol Exp Ther; 1993 Jul; 266(1):121-4. PubMed ID: 8101214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.
    Tan-No K; Cebers G; Yakovleva T; Hoon Goh B; Gileva I; Reznikov K; Aguilar-Santelises M; Hauser KF; Terenius L; Bakalkin G
    Exp Cell Res; 2001 Sep; 269(1):54-63. PubMed ID: 11525639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin (1-13): analgesia, hypothermia, cross-tolerance with morphine and beta-endorphin.
    Petrie EC; Tiffany ST; Baker TB; Dahl JL
    Peptides; 1982; 3(1):41-7. PubMed ID: 6281745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effect of dynorphin-(1-13) on luteinizing hormone release in conscious castrated rats.
    Kinoshita F; Nakai Y; Katakami H; Imura H
    Life Sci; 1982 May; 30(22):1915-9. PubMed ID: 6287134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1997 Jan; 280(1):416-21. PubMed ID: 8996223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonopiate effects of dynorphin and des-Tyr-dynorphin.
    Walker JM; Moises HC; Coy DH; Baldrighi G; Akil H
    Science; 1982 Dec; 218(4577):1136-8. PubMed ID: 6128791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of distinct sites of beta-endorphin that stimulate lymphokine production by murine CD4+ T cells.
    Van den Bergh P; Rozing J; Nagelkerken L
    Lymphokine Cytokine Res; 1994 Apr; 13(2):63-9. PubMed ID: 7914752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate antagonists do not alter neuronal responses to stimulation of opioid-containing pathways in rat hippocampus.
    Chavkin C; Bloom FE
    Neuropeptides; 1986 Jan; 7(1):19-22. PubMed ID: 2869440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nociceptive behavior induced by the endogenous opioid peptides dynorphins in uninjured mice: evidence with intrathecal N-ethylmaleimide inhibiting dynorphin degradation.
    Tan-No K; Takahashi H; Nakagawasai O; Niijima F; Sakurada S; Bakalkin G; Terenius L; Tadano T
    Int Rev Neurobiol; 2009; 85():191-205. PubMed ID: 19607971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites.
    Hauser KF; Knapp PE; Turbek CS
    Exp Neurol; 2001 Mar; 168(1):78-87. PubMed ID: 11170722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.